Targeting IL-6 to prevent cardiac allograft rejection.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons(2022)
摘要
Outcomes following heart transplantation remain suboptimal with acute and chronic rejection being major contributors to poor long-term survival. IL-6 is increasingly recognized as a critical pro-inflammatory cytokine involved in allograft injury and has been shown to play a key role in regulating the inflammatory and alloimmune responses following heart transplantation. Therapies that inhibit IL-6 signaling have emerged as promising strategies to prevent allograft rejection. Here, we review experimental and pre-clinical evidence that supports the potential use of IL-6 signaling blockade to improve outcomes in heart transplant recipients.
更多查看译文
关键词
basic (laboratory) research/science,cytokines/cytokine receptors,heart (allograft) function/dysfunction,heart transplantation/cardiology,immunosuppressant-fusion proteins and monoclonal antibodies,immunosuppression/immune modulation,rejection: acute,rejection: chronic,solid organ transplantation,translational research/science
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要